HAP Trading’s Array Biopharma Inc ARRY Stock Holding History

HAP Trading’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-176,200	Closed	-$49K	–	1209
2018 Q1	$49K	Buy	+176,200	New	+$2.82M	﹤0.01%	648
2017 Q3	–	Sell	-228,100	Closed	-$209K	–	1158
2017 Q2	$209K	Sell	228,100 -8,700	-4%	-$71.1K	0.01%	505
2017 Q1	$369K	Buy	+236,800	New	+$2.52M	0.02%	383
2015 Q3	–	Sell	-200,000	Closed	-$35K	–	1255
2015 Q2	$35K	Buy	+200,000	New	+$1.48M	﹤0.01%	720

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

HAP Trading's ARRY Position: Q2 2018 in Review

HAP Trading sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 110,000 shares — an estimated $1.79M sold.

HAP Trading first reported a position in ARRY in Q1 2017 and held it in 3 quarters. The position peaked at $1.79M in Q1 2018. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

HAP Trading reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
HAP Trading sold 110,000 Array Biopharma Inc shares in Q2 2018, an estimated $1.79M.
HAP Trading first reported a position in Array Biopharma Inc in Q1 2017 and held it in 3 quarters.
HAP Trading's Array Biopharma Inc position peaked at $1.79M in Q1 2018.
223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on HAP Trading's 13F filing for Q2 2018, filed 13 Aug 2018.